Caprock Group, Inc. Astrazeneca PLC Transaction History
Caprock Group, Inc.
- $1.72 Billion
- Q1 2024
A detailed history of Caprock Group, Inc. transactions in Astrazeneca PLC stock. As of the latest transaction made, Caprock Group, Inc. holds 10,450 shares of AZN stock, worth $808,203. This represents 0.04% of its overall portfolio holdings.
Number of Shares
10,450
Previous 9,211
13.45%
Holding current value
$808,203
Previous $620,000
14.03%
% of portfolio
0.04%
Previous 0.04%
Shares
22 transactions
Others Institutions Holding AZN
# of Institutions
1,248Shares Held
477MCall Options Held
5.99MPut Options Held
5.24M-
Price T Rowe Associates Inc Baltimore, MD61.3MShares$4.74 Billion0.51% of portfolio
-
Wellington Management Group LLP Boston, MA49.1MShares$3.8 Billion0.6% of portfolio
-
Primecap Management CO Pasadena, CA42.9MShares$3.32 Billion2.21% of portfolio
-
Capital International Investors Los Angeles, CA34.5MShares$2.67 Billion0.48% of portfolio
-
Jennison Associates LLC17.3MShares$1.34 Billion0.79% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $240B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...